Schedule 13G ownership disclosure
INOVIO PHARMACEUTICALS INC
Common Stock · CUSIP: 45773H409
Event date: 2024-12-31
- Filing-level shares
- 1,673,587
- Percent of class
- 4.64%
- The Vanguard Group
Shares: 1,673,587 · Class: 4.64%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000174
- Form type
- SCHEDULE 13G/A
- Filer
- INOVIO PHARMACEUTICALS, INC.
- CIK
- CIK 1055726
- Filed
- Jan 30, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership